Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessEarnings Release is IBM (IBM) a Buy?

Earnings Release is IBM (IBM) a Buy?

Add to Favorite
Added to Favorite

 

IBM reported first-quarter net income of $955 million, or $1.06 a share, compared with $1.18 billion, or $1.31 a share, in the year-ago period. Revenue rose to $17.73 billion from $17.57 billion in the year-ago quarter. Adjusted earnings, which exclude stock-based compensation expenses and other items, were $1.77 a share, compared with $1.84 a share in the year-ago period.

Analysts had estimated $1.69 a share and a decline in revenue to $17.32 billion for the first quarter.

 

“Strong performance this quarter in cloud, driven by increasing client adoption of our hybrid cloud platform, and growth in software and consulting enabled us to get off to a solid start for the year,” said Chairman and Chief Executive Arvind Krishna in a statement. “While we have more work to do, we are confident we can achieve full-year revenue growth, and meet our adjusted free cash flow target in 2021.”

Global technology services, or GTS, posted $6.37 billion in revenue compared with $6.47 billion in the year-ago quarter and the $6.32 billion Street consensus.

The company reported cloud- and cognitive-software revenue — which includes its Red Hat unit — of $5.44 billion compared with $5.24 billion a year ago, while analysts had been expecting $5.48 billion.

Total cloud revenue, which draws from various business units, grew 21% to $6.5 billion from a year ago, IBM said.

Global business services revenue was $4.23 billion, compared with $4.14 billion a year ago, and Street forecasts of $4.03 billion. Systems revenue was $1.43 billion, compared with $1.37 billion a year ago and analysts’ expectations of $1.29 billion.

IBM said it expects ” to grow revenue for the full-year 2021 based on mid-April 2021 foreign exchange rates.” Analysts expect full-year revenue of $74.07 billion, or a gain of 0.6% from 2020.

“Strong performance this quarter in cloud, driven by increasing client adoption of our hybrid cloud platform and growth in software
and consulting enabled us to get off to a solid start for the year.
We are confident we can achieve full-year revenue growth and meet our adjusted free cash flow target in 2021.”

– Arvind Krishna, IBM Chairman and CEO

 

Subscribe to get Latest News Updates

Latest News

You may like more
more

Advance Auto Parts Downgraded to Sell Amid Earnings Miss and Weak Outlook

CFRA analysts downgraded Advance Auto Parts (NYSE:AAP) from Hold...

Guggenheim Reiterates Buy Rating on Cabaletta Bio Amid Promising Data

Guggenheim analysts reaffirmed a Buy rating and a $23...

Goldman Sachs Initiates Neutral Coverage on Doximity, Highlights Balanced Growth Potential

Goldman Sachs analysts initiated coverage on Doximity (NYSE:DOCS) with...